A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy
Clinical trial NCT00067782 · COMPLETED
Trial details
- NCT number
- NCT00067782
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2005-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.